Add like
Add dislike
Add to saved papers

Prognosis of acute post-streptococcal glomerulonephritis in Sudanese children.

INTRODUCTION: Acute post streptococcal glomerulo-nephritis (APSGN) is a form of acute nephritic syndrome characterized by edema, hematuria, proteinuria, and hypertension. The immediate prognosis of acute post-streptococcal glomerulonephritis in children is usually excellent, however, the long-term prognosis has been a subject of debate.

METHODS: This is a retrospective and prospective cohort study of Sudanese children with APSGN followed in a tertiary care hospital between 2006 and 2010. Patients who presented for follow-up 1-5 years after initial diagnosis were assessed for proteinuria, hematuria, urinary albumin to creatinine ratio (ACR), hypertension, and glomerular filtration rate (GFR).

RESULTS: Data of 69 children (46 males; 66.7%) was analyzed. At presentation, 29% had severe acute disease requiring dialysis. On discharge, 60 children (87%) recovered their renal function, seven children (10.1%) showed no recovery and two children (2.9%) died. Forty out of 69 children presented to follow-up 1-5 years after initial diagnosis. Thirty-four of these children (85%) had normal blood pressure and GFR while six children (15%) progressed to chronic kidney disease (CKD); three of whom died. Among children with normal GFR, eight (23.5%) had microalbuminuria plus hematuria and four (11.7%) had hematuria. Persistence of proteinuria and/or hematuria was universal among the 14 children with normal GFR who continued follow-up more than three years after initial presentation.

CONCLUSION: APSGN in this group of Sudanese children had a less favorable prognosis. This reflects the tertiary care set-up of this study. Persistence of hematuria and/or proteinuria was common on follow-up.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app